{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:53:57Z","timestamp":1791575637211,"version":"4.3.4"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014849","name":"Government of Valencia Department of Education Culture and University","doi-asserted-by":"publisher","award":["CIAICO\/2023\/099"],"award-info":[{"award-number":["CIAICO\/2023\/099"]}],"id":[{"id":"10.13039\/501100014849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.arbres.2026.09.002","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:32:26Z","timestamp":1790890346000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pushing the Boundaries of Knowledge in Alpha-1 Antitrypsin Deficiency"],"prefix":"10.1016","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Hern\u00e1ndez-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Castillo-Corull\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ferrarotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Mart\u00ednez-Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Casas-Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"Das\u00ed-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2026.09.002_bib0650","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJMra1910234","article-title":"Alpha1-antitrypsin deficiency","volume":"382","author":"Strnad","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0655","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013167","article-title":"Development of a small molecule that corrects misfolding and increases secretion of Z \u03b11-antitrypsin","volume":"13","author":"Lomas","year":"2021","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0660","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0140-6736(05)66781-5","article-title":"\u03b11-Antitrypsin deficiency","volume":"365","author":"Stoller","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2026.09.002_bib0665","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13023-018-0856-9","article-title":"Alpha-1 antitrypsin deficiency: outstanding questions and future directions","volume":"13","author":"Torres-Dur\u00e1n","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib0670","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.medcli.2023.10.014","article-title":"Alpha-1 antitrypsin deficiency","volume":"162","author":"Das\u00ed","year":"2024","journal-title":"Med Cl\u00edn"},{"key":"10.1016\/j.arbres.2026.09.002_bib0675","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00610-2017","article-title":"European Respiratory Society statement: diagnosis and treatment of pulmonary disease in \u03b11-antitrypsin deficiency","volume":"50","author":"Miravitlles","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.09.002_bib0680","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/COPD.S125389","article-title":"Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update","volume":"12","author":"Blanco","year":"2017","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2026.100606","article-title":"Decalogue of best practices in alpha-1 antitrypsin deficiency","volume":"8","author":"Hern\u00e1ndez-P\u00e9rez","year":"2026","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.arbres.2026.09.002_bib0690","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1097\/MS9.0000000000003393","article-title":"Fazirsiran for the treatment of alpha-1 antitrypsin deficiency-associated liver disease findings from the SEQUOIA phase 2 trial","volume":"87","author":"Liaquat","year":"2025","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.arbres.2026.09.002_bib0695","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2205416","article-title":"Fazirsiran for liver disease associated with alpha1-antitrypsin deficiency","volume":"387","author":"Strnad","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0700","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jhep.2016.03.010","article-title":"Update on alpha-1 antitrypsin deficiency: new therapies","volume":"65","author":"Lomas","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.arbres.2026.09.002_bib0705","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.4049\/jimmunol.0802864","article-title":"Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency","volume":"184","author":"Carroll","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.arbres.2026.09.002_bib0710","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.chest.2018.04.039","article-title":"\u03b11-Antitrypsin polymerizes in alveolar macrophages of smokers with and without \u03b11-antitrypsin deficiency","volume":"154","author":"Bazzan","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2026.09.002_bib0715","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12931-014-0112-3","article-title":"The role of bronchial epithelial cells in the pathogenesis of COPD in Z-alpha-1 antitrypsin deficiency","volume":"15","author":"Pini","year":"2014","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib0720","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.3390\/jcm10061268","article-title":"Oxidative stress and endoplasmic reticulum stress in rare respiratory diseases","volume":"10","author":"Magall\u00f3n","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0725","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/TACG.S257511","article-title":"Known mutations at the cause of alpha-1 antitrypsin deficiency an updated overview of SERPINA1 variation spectrum","volume":"14","author":"Seixas","year":"2021","journal-title":"Appl Clin Genet"},{"key":"10.1016\/j.arbres.2026.09.002_bib0730","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12931-025-03486-1","article-title":"Functional and clinical significance of novel SERPINA1 variants on alpha-1 antitrypsin deficiency","volume":"27","author":"Matamala","year":"2026","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib0735","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1165\/rcmb.2022-0470OC","article-title":"Comprehensive clinical diagnostic pipelines reveal new variants in alpha-1 antitrypsin deficiency","volume":"69","author":"Ottaviani","year":"2023","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.arbres.2026.09.002_bib0740","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00228-2025","article-title":"The phenotypic state of biallelic SERPINA1 Q0 variants in \u03b11-antitrypsin deficiency","volume":"11","author":"Papiris","year":"2025","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib0745","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc1370","article-title":"The structural basis for Z \u03b11-antitrypsin polymerization in the liver","volume":"6","author":"Faull","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.arbres.2026.09.002_bib0750","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/1471-2466-14-132","article-title":"The significance of the F variant of alpha-1-antitrypsin and unique case report of a PiFF homozygote","volume":"14","author":"Sinden","year":"2014","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0755","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2119\/molmed.2011.00207","article-title":"Effect of cigarette smoke exposure and structural modifications on the \u03b1-1 antitrypsin interaction with caspases","volume":"18","author":"Lockett","year":"2012","journal-title":"Mol Med"},{"issue":"Suppl. 2","key":"10.1016\/j.arbres.2026.09.002_bib0760","first-page":"S146","article-title":"Alpha-1 antitrypsin and lung cell apoptosis","volume":"13","author":"Serban","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.arbres.2026.09.002_bib0765","doi-asserted-by":"crossref","DOI":"10.1080\/25310429.2024.2429911","article-title":"Clinical features in patients with severe Alpha-1 antitrypsin deficiency due to rare genotypes","volume":"31","author":"Ferrarotti","year":"2025","journal-title":"Pulmonology"},{"key":"10.1016\/j.arbres.2026.09.002_bib0770","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41586-025-08885-4","article-title":"Deep visual proteomics maps proteotoxicity in a genetic liver disease","volume":"642","author":"Rosenberger","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.arbres.2026.09.002_bib0775","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41588-025-02125-1","article-title":"Selection for somatic escape variants in SERPINA1 in the liver of patients with alpha-1 antitrypsin deficiency","volume":"57","author":"Brzozowska","year":"2025","journal-title":"Nat Genet"},{"key":"10.1016\/j.arbres.2026.09.002_bib0780","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.arbres.2024.06.019","article-title":"Sex-differences in alpha-1 antitrypsin deficiency: data from the EARCO Registry","volume":"61","author":"Ers\u00f6z","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2026.09.002_bib0785","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1164\/rccm.168.7.818","article-title":"American Thoracic Society\/European Respiratory Society Statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency","volume":"168","author":"Society","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0790","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2147\/COPD.S155226","article-title":"Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT)","volume":"13","author":"Esquinas","year":"2018","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib0795","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12931-022-02275-4","article-title":"Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry","volume":"23","author":"Miravitlles","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib0800","doi-asserted-by":"crossref","first-page":"e15269","DOI":"10.1111\/ped.15269","article-title":"Alpha-1 antitrypsin deficiency: PI*Mpalermo and PI*Siiyama, current damage and future risk","volume":"64","author":"Hern\u00e1ndez-P\u00e9rez","year":"2022","journal-title":"Pediatr Int"},{"key":"10.1016\/j.arbres.2026.09.002_bib0805","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1164\/rccm.200406-761OC","article-title":"Pattern of emphysema distribution in \u03b11-antitrypsin deficiency influences lung function impairment","volume":"170","author":"Parr","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0810","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/thx.2006.075846","article-title":"Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency","volume":"62","author":"DeMeo","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2026.09.002_bib0815","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S8756-3452(08)79052-2","article-title":"Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency","volume":"2009","author":"Maurer","year":"2009","journal-title":"Yearb Pulm Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib0820","doi-asserted-by":"crossref","first-page":"100310","DOI":"10.1016\/j.opresp.2024.100310","article-title":"Diagnosis of alpha-1 antitrypsin deficiency (AATD) in primary care","volume":"6","author":"Barrecheguren","year":"2024","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.arbres.2026.09.002_bib0825","first-page":"668","article-title":"The diagnosis and management of alpha-1 antitrypsin deficiency in the adult","volume":"3","author":"Sandhaus","year":"2016","journal-title":"Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib0830","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1177\/1753465815602162","article-title":"Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis","volume":"10","author":"Greulich","year":"2016","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib0835","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1378\/chest.128.3.1179","article-title":"Trends in the diagnosis of symptomatic patients with (1-antitrypsin deficiency between 1968 and 2003","volume":"128","author":"Campos","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2026.09.002_bib0840","doi-asserted-by":"crossref","DOI":"10.1016\/j.opresp.2023.100251","article-title":"Resultados de la implementaci\u00f3n de un programa de detecci\u00f3n de casos de d\u00e9ficit de alfa-1 antitripsina en pacientes con EPOC","volume":"5","author":"Reinoso-Arija","year":"2023","journal-title":"Open Respir Arch"},{"key":"10.1016\/j.arbres.2026.09.002_bib0845","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jmoldx.2024.08.002","article-title":"Haplotype-aware detection of SERPINA1 variants by nanopore sequencing","volume":"26","author":"Gonz\u00e1lez-Carracedo","year":"2024","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.arbres.2026.09.002_bib0850","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3390\/medicina62040639","article-title":"Alpha-1 antitrypsin deficiency-associated chronic obstructive pulmonary disease","volume":"62","author":"Fouka","year":"2026","journal-title":"Medicina"},{"key":"10.1016\/j.arbres.2026.09.002_bib0855","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.arbres.2020.04.014","article-title":"Results of a diagnostic procedure based on multiplex technology on dried blood spots and buccal swabs for subjects with suspected alpha1 antitrypsin deficiency","volume":"57","author":"Lopez-Campos","year":"2021","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.arbres.2026.09.002_bib0860","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.arbr.2011.02.012","article-title":"Diagnosis of alpha-1 antitrypsin deficiency: limitations of rapid diagnostic laboratory tests","volume":"47","author":"Rodr\u00edguez-Fr\u00edas","year":"2011","journal-title":"Arch Bronconeumol (Engl Ed)"},{"key":"10.1016\/j.arbres.2026.09.002_bib0865","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12931-022-02074-x","article-title":"Feasibility of a genotyping system for the diagnosis of alpha1 antitrypsin deficiency: a multinational cross-sectional analysis","volume":"23","author":"Lopez-Campos","year":"2022","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib0870","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40246-023-00497-1","article-title":"Distribution of alpha1 antitrypsin rare alleles in six countries: Results from the Progenika diagnostic network","volume":"17","author":"Lopez-Campos","year":"2023","journal-title":"Hum Genom"},{"key":"10.1016\/j.arbres.2026.09.002_bib0875","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1080\/15412550902905961","article-title":"Augmentation therapy for alpha1 antitrypsin deficiency: a meta-analysis","volume":"6","author":"Chapman","year":"2009","journal-title":"COPD"},{"key":"10.1016\/j.arbres.2026.09.002_bib0880","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1183\/09031936.00159408","article-title":"Exploring the role of CT densitometry: a randomised study of augmentation therapy in alpha1-antitrypsin deficiency","volume":"33","author":"Dirksen","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.09.002_bib0885","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe \u03b11 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2026.09.002_bib0890","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1183\/09031936.00174807","article-title":"Desmosine as a biomarker of elastin degradation in COPD: current status and future directions","volume":"32","author":"Luisetti","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.09.002_bib0895","first-page":"34","article-title":"The effect of alpha-1 proteinase inhibitor on biomarkers of elastin degradation in alpha-1 antitrypsin deficiency: an analysis of the RAPID\/RAPID extension trials","volume":"4","author":"Ma","year":"2017","journal-title":"Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib0900","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1164\/rccm.202002-0434LE","article-title":"Serum desmosine is associated with long-term all-cause and cardiovascular mortality in bronchiectasis","volume":"202","author":"Huang","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0905","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1183\/13993003.01824-2015","article-title":"Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD","volume":"47","author":"Rabinovich","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.09.002_bib0910","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1136\/thx.2010.154690","article-title":"The fibrinogen cleavage product A\u03b1-Val360, a specific marker of neutrophil elastase activity in vivo","volume":"66","author":"Carter","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.arbres.2026.09.002_bib0915","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.00197411","article-title":"A-Val360: a marker of neutrophil elastase and COPD disease activity","volume":"41","author":"Carter","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.09.002_bib0920","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3390\/biom12030380","article-title":"The relationship between plasma alpha-1-antitrypsin polymers and lung or liver function in ZZ alpha-1-antitrypsin-deficient patients","volume":"12","author":"Sark","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.arbres.2026.09.002_bib0925","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1378\/chest.14-0520","article-title":"The relationship of the fibrinogen cleavage biomarker Aa-Val360 with disease severity and activity in \u03b11-antitrypsin deficiency","volume":"148","author":"Carter","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2026.09.002_bib0930","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1164\/rccm.201509-1722PP","article-title":"Plasma fibrinogen qualification as a drug development tool in chronic obstructive pulmonary disease: perspective of the chronic obstructive pulmonary disease biomarker qualification consortium","volume":"193","author":"Miller","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0935","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037483","article-title":"Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype","volume":"7","author":"Agust\u00ed","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.arbres.2026.09.002_bib0940","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1465-9921-12-146","article-title":"COPD association and repeatability of blood biomarkers in the ECLIPSE cohort","volume":"12","author":"Dickens","year":"2011","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib0945","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000548597","article-title":"Routine blood biomarkers and lung disease in patients with alpha-1 antitrypsin deficiency from the EARCO Registry","volume":"105","author":"Aljama","year":"2026","journal-title":"Respiration"},{"key":"10.1016\/j.arbres.2026.09.002_bib0950","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.arbres.2025.12.013","article-title":"Routine Blood Biomarkers in Patients With the PI*SZ Genotype of Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry","volume":"62","author":"Lopez-Gonzalez","year":"2026","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.arbres.2026.09.002_bib0955","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3390\/biomedicines11072001","article-title":"Predicting lung function using biomarkers in alpha-1 antitrypsin deficiency","volume":"11","author":"Spittle","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.arbres.2026.09.002_bib0960","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S2213-2600(15)00196-4","article-title":"Relation between circulating CC16 concentrations, lung function, and development of chronic obstructive pulmonary disease across the lifespan: a prospective study","volume":"3","author":"Guerra","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104262","article-title":"Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease","volume":"84","author":"Serban","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.arbres.2026.09.002_bib0970","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2019.05.013","article-title":"Liver fibrosis and metabolic alterations in adults with alpha-1-antitrypsin deficiency caused by the Pi*ZZ mutation","volume":"157","author":"Hamesch","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arbres.2026.09.002_bib0975","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.cgh.2012.07.007","article-title":"Liver test results do not identify liver disease in adults with \u03b11-antitrypsin deficiency","volume":"10","author":"Clark","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.arbres.2026.09.002_bib0980","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10081724","article-title":"Utility of transient elastography for the screening of liver disease in patients with alpha1-antitrypsin deficiency","volume":"10","author":"Pons","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib0985","first-page":"260","article-title":"Non-invasive assessment and management of liver involvement in adults with alpha-1 antitrypsin deficiency","volume":"7","author":"Hamesch","year":"2020","journal-title":"Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib0990","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"Tacke","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.arbres.2026.09.002_bib0995","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.arbres.2026.09.002_bib1000","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1053\/j.gastro.2025.12.012","article-title":"Multi-society expert panel consensus guidance regarding clinical assessment and clinical trial endpoints in adults with alpha-1 antitrypsin deficiency-associated liver disease","volume":"170","author":"Loomba","year":"2026","journal-title":"Gastroenterology"},{"key":"10.1016\/j.arbres.2026.09.002_bib1005","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12931-021-01842-5","article-title":"Association between circulating alpha-1 antitrypsin polymers and lung and liver disease","volume":"22","author":"N\u00fa\u00f1ez","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib1010","first-page":"151","article-title":"The alpha-1 antitrypsin polymer load correlates with hepatocyte senescence fibrosis stage and liver-related mortality","volume":"7","author":"Mela","year":"2020","journal-title":"Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib1015","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1111\/liv.16094","article-title":"Fibrosis, biomarkers and liver biopsy in AAT deficiency and relation to liver Z protein polymer accumulation","volume":"44","author":"Suri","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.arbres.2026.09.002_bib1020","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jhep.2021.11.022","article-title":"Alpha-1 antitrypsin deficiency: a re-surfacing adult liver disorder","volume":"76","author":"Fromme","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.arbres.2026.09.002_bib1025","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/357605a0","article-title":"The mechanism of Z \u03b11-antitrypsin accumulation in the liver","volume":"357","author":"Lomas","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.arbres.2026.09.002_bib1030","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jhep.2018.08.005","article-title":"Clinical and histologic features of adults with alpha-1 antitrypsin deficiency in a non-cirrhotic cohort","volume":"69","author":"Clark","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.arbres.2026.09.002_bib1035","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/ueg2.12629","article-title":"Association of circulating Z-polymer with adverse clinical outcomes and liver fibrosis in adults with alpha-1 antitrypsin deficiency","volume":"12","author":"Fromme","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.arbres.2026.09.002_bib1040","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1717317","article-title":"Circulating C-terminal peptides and polymers of alpha-1 antitrypsin as putative markers of pediatric Pi*ZZ liver disease","volume":"13","author":"Katzer","year":"2025","journal-title":"Front Pediatr"},{"key":"10.1016\/j.arbres.2026.09.002_bib1045","doi-asserted-by":"crossref","first-page":"44865","DOI":"10.1074\/jbc.M103703200","article-title":"The proteasome participates in degradation of mutant alpha 1-antitrypsin Z in the endoplasmic reticulum of hepatoma-derived hepatocytes","volume":"276","author":"Teckman","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.arbres.2026.09.002_bib1050","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1190354","article-title":"An autophagy-enhancing drug promotes degradation of mutant \u03b11-antitrypsin Z and reduces hepatic fibrosis","volume":"329","author":"Hidvegi","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.arbres.2026.09.002_bib1055","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-1-4939-8645-3_7","article-title":"Cellular models for the serpinopathies","volume":"1826","author":"Fra","year":"2018","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"10.1016\/j.arbres.2026.09.002_bib1060","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s10529-016-2150-z","article-title":"Recombinant production of native human \u03b1-1-antitrypsin protein in the liver HepG2 cells","volume":"38","author":"Jaberie","year":"2016","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.arbres.2026.09.002_bib1065","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1002\/hep4.1997","article-title":"The unfolded protein response to PI*Z alpha-1 antitrypsin in human hepatocellular and murine models","volume":"6","author":"Lu","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.arbres.2026.09.002_bib1070","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nprot.2012.153","article-title":"Production of hepatocyte-like cells from human pluripotent stem cells","volume":"8","author":"Hannan","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.arbres.2026.09.002_bib1075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature10424","article-title":"Targeted gene correction of \u03b11-antitrypsin deficiency in induced pluripotent stem cells","volume":"478","author":"Yusa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.arbres.2026.09.002_bib1080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.27753","article-title":"Induced pluripotent stem cells model personalized variations in liver disease resulting from \u03b11-antitrypsin deficiency","volume":"62","author":"Tafaleng","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.arbres.2026.09.002_bib1085","first-page":"258","article-title":"Patient-derived induced pluripotent stem cells for alpha-1 antitrypsin deficiency disease modeling and therapeutic discovery","volume":"5","author":"Kaserman","year":"2018","journal-title":"Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.arbres.2026.09.002_bib1090","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","article-title":"Long-term culture of genome-stable bipotent stem cells from adult human liver","volume":"160","author":"Huch","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.arbres.2026.09.002_bib1095","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12072-019-10007-y","article-title":"Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease","volume":"14","author":"G\u00f3mez-Mariano","year":"2020","journal-title":"Hepatol Int"},{"key":"10.1016\/j.arbres.2026.09.002_bib1100","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111775","article-title":"Human iPSC-hepatocyte modeling of alpha-1 antitrypsin heterozygosity reveals metabolic dysregulation and cellular heterogeneity","volume":"41","author":"Kaserman","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.arbres.2026.09.002_bib1105","doi-asserted-by":"crossref","first-page":"12472","DOI":"10.3390\/ijms241512472","article-title":"Quantitative lipid profiling reveals major differences between liver organoids with normal Pi*M and deficient Pi*Z variants of alpha-1-antitrypsin","volume":"24","author":"P\u00e9rez-Luz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arbres.2026.09.002_bib1110","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI113999","article-title":"Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice","volume":"83","author":"Carlson","year":"1989","journal-title":"J Clin Investig"},{"key":"10.1016\/j.arbres.2026.09.002_bib1115","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/mt.2015.174","article-title":"Efficient and targeted transduction of nonhuman primate liver with systemically delivered optimized AAV3B vectors","volume":"23","author":"Li","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/hep.20815","article-title":"Alpha-1-antitrypsin deficiency: A new paradigm for hepatocellular carcinoma in genetic liver disease","volume":"42","author":"Rudnick","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.arbres.2026.09.002_bib1125","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.1713689115","article-title":"Editing out five Serpina1 paralogs to create a mouse model of genetic emphysema","volume":"115","author":"Borel","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.arbres.2026.09.002_bib1130","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1177\/10430342261417356","article-title":"Advances in Precision Editing Therapies for Alpha-1 Antitrypsin Deficiency","volume":"37","author":"Gao","year":"2026","journal-title":"Hum Gene Ther."},{"key":"10.1016\/j.arbres.2026.09.002_bib1135","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/hum.2017.227","article-title":"Amelioration of alpha-1 antitrypsin deficiency diseases with genome editing in transgenic mice","volume":"29","author":"Shen","year":"2018","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1140","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.ymthe.2017.09.020","article-title":"Survival advantage of both human hepatocyte xenografts and genome-edited hepatocytes for treatment of \u03b1-1 antitrypsin deficiency","volume":"25","author":"Borel","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1145","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1089\/hum.1996.7.4-531","article-title":"Human 1-antitrypsin gene transfer to in vivo mouse hepatocytes","volume":"7","author":"Alio","year":"1996","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s001090000185","article-title":"Asialofetuin liposome-mediated human alpha1-antitrypsin gene transfer in vivo results in stationary long-term gene expression","volume":"79","author":"Das\u00ed","year":"2001","journal-title":"J Mol Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib1155","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.gt.3302469","article-title":"Hydrodynamic liver gene transfer mechanism involves transient sinusoidal blood stasis and massive hepatocyte endocytic vesicles","volume":"12","author":"Crespo","year":"2005","journal-title":"Gene Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1160","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1038\/sj.gt.3302065","article-title":"Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA","volume":"10","author":"Ali\u00f1o","year":"2003","journal-title":"Gene Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1165","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1016\/j.ymthe.2025.08.040","article-title":"A compact base editor rescues AATD-associated liver and lung disease in mouse models","volume":"33","author":"Gao","year":"2025","journal-title":"Mol Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1170","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.ymthe.2021.06.021","article-title":"Adenine base editing reduces misfolded protein accumulation and toxicity in alpha-1 antitrypsin deficient patient iPSC-hepatocytes","volume":"29","author":"Werder","year":"2021","journal-title":"Mol Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1175","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/14712598.2023.2183771","article-title":"Gene therapy for alpha-1 antitrypsin deficiency: an update","volume":"23","author":"Ferreira","year":"2023","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1180","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.chest.2024.09.038","article-title":"Editing approaches to treat alpha-1 antitrypsin deficiency","volume":"167","author":"Erion","year":"2025","journal-title":"Chest"},{"key":"10.1016\/j.arbres.2026.09.002_bib1185","doi-asserted-by":"crossref","first-page":"gkaf1518","DOI":"10.1093\/nar\/gkaf1518","article-title":"RNA editing for the treatment of alpha-1 antitrypsin deficiency","volume":"54","author":"Monian","year":"2026","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib1190","doi-asserted-by":"crossref","first-page":"7347","DOI":"10.1097\/MS9.0000000000003913","article-title":"Alpha-1 antitrypsin deficiency: genetics, clinical manifestations, AI prognostics, and advanced imaging in liver disease","volume":"87","author":"Rajab","year":"2025","journal-title":"Ann Med Surg"},{"key":"10.1016\/j.arbres.2026.09.002_bib1195","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/ijms21041493","article-title":"Alpha 1-antitrypsin deficiency: a disorder of proteostasis-mediated protein folding and trafficking pathways","volume":"21","author":"Karatas","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.arbres.2026.09.002_bib1200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13578-022-00783-w","article-title":"Pharmacological activation of ATF6 remodels the proteostasis network to rescue pathogenic GABAA receptors","volume":"12","author":"Wang","year":"2022","journal-title":"Cell Biosci"},{"key":"10.1016\/j.arbres.2026.09.002_bib1205","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2022.12.004","article-title":"Capturing the conversion of the pathogenic alpha-1-antitrypsin fold by ATF6 enhanced proteostasis","volume":"30","author":"Sun","year":"2023","journal-title":"Cell Chem Biol"},{"key":"10.1016\/j.arbres.2026.09.002_bib1210","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/hep.26615","article-title":"Repopulation of the fibrotic\/cirrhotic rat liver by transplanted hepatic stem\/progenitor cells and mature hepatocytes","volume":"59","author":"Yovchev","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.arbres.2026.09.002_bib1215","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1183\/09031936.00096508","article-title":"Mechanisms of emphysema in \u03b11-antitrypsin deficiency: molecular and cellular insights","volume":"34","author":"Gooptu","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.09.002_bib1220","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1074\/mcp.M116.066746","article-title":"Paucimannose-rich N-glycosylation of spatiotemporally regulated human neutrophil elastase modulates its immune functions","volume":"16","author":"Loke","year":"2017","journal-title":"Mol Cell Proteom"},{"key":"10.1016\/j.arbres.2026.09.002_bib1225","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/fcp.12946","article-title":"Human neutrophil elastase inhibitors: classification, biological-synthetic sources and their relevance in related diseases","volume":"38","author":"Ocampo-Gallego","year":"2024","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.arbres.2026.09.002_bib1230","article-title":"Research progress on the effect of neutrophil elastase and its inhibitors in respiratory diseases","volume":"53","author":"Liang","year":"2025","journal-title":"J Int M\u00e9d Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib1235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12931-025-03100-4","article-title":"Neutrophil elastase inhibitor (Sivelestat) in the treatment of acute respiratory distress syndrome induced by COVID-19: a multicenter retrospective cohort study","volume":"26","author":"Li","year":"2025","journal-title":"Respir Res"},{"key":"10.1016\/j.arbres.2026.09.002_bib1240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jcf.2019.08.020","article-title":"Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis","volume":"19","author":"Barth","year":"2020","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.arbres.2026.09.002_bib1245","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.1038\/srep08347","article-title":"Sirtinol inhibits neutrophil elastase activity and attenuates lipopolysaccharide-mediated acute lung injury in mice","volume":"5","author":"Tsai","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.arbres.2026.09.002_bib1250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1124\/jpet.111.182139","article-title":"AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase","volume":"339","author":"Stevens","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1255","doi-asserted-by":"crossref","first-page":"288","DOI":"10.5414\/CP201674","article-title":"Pharmacokinetics and safety of AZD9668, an oral neutrophil elastase inhibitor, in healthy volunteers and patients with COPD","volume":"51","author":"Gunawardena","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.arbres.2026.09.002_bib1260","doi-asserted-by":"crossref","first-page":"2501019","DOI":"10.1183\/13993003.01019-2025","article-title":"Two randomised controlled phase 2 studies of the oral neutrophil elastase inhibitor alvelestat in alpha-1 antitrypsin deficiency","volume":"66","author":"Wells","year":"2025","journal-title":"Eur Respir J"},{"key":"10.1016\/j.arbres.2026.09.002_bib1265","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1164\/ajrccm.161.3.9906011","article-title":"Feasibility of a clinical trial of augmentation therapy for \u03b11-antitrypsin deficiency","volume":"161","author":"Schluchter","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib1270","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051708","article-title":"SERPINA1 and more? A putative genetic contributor to pulmonary dysfunction in alpha-1 antitrypsin deficiency","volume":"12","author":"Jezela-Stanek","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib1275","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.550543","article-title":"SERPINA1 gene promoter is differentially methylated in peripheral blood mononuclear cells of pregnant women","volume":"8","author":"Rotondo","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.arbres.2026.09.002_bib1280","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12967-015-0585-y","article-title":"Alternative transcripts of the SERPINA1 gene in alpha-1 antitrypsin deficiency","volume":"13","author":"Matamala","year":"2015","journal-title":"J Transl Med"},{"key":"10.1016\/j.arbres.2026.09.002_bib1285","doi-asserted-by":"crossref","first-page":"E10244","DOI":"10.1073\/pnas.1706539114","article-title":"An RNA structure-mediated, posttranscriptional model of human \u03b1-1-antitrypsin expression","volume":"114","author":"Corley","year":"2017","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.arbres.2026.09.002_bib1290","article-title":"miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary Disease","volume":"18","author":"Matamala","year":"2020","journal-title":"Arch Bronconeumol"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626003510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289626003510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:40:59Z","timestamp":1791574859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289626003510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":129,"alternative-id":["S0300289626003510"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2026.09.002","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pushing the Boundaries of Knowledge in Alpha-1 Antitrypsin Deficiency","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2026.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Espa\u00f1a, S.L.U. on behalf of SEPAR.","name":"copyright","label":"Copyright"}]}}